AzTrials
AzTrials

EndometriosisNCT07087756

The Effect of Temporary Ovarian Suspension to the Abdominal Wall During Laparoscopic Endometriosis Surgery for Adhesion Prevention -A Comparative and Prospective Study

A study testing laparoscopic ovarian suspension in people with Endometriosis and Abdominal Adhesions, run by Carmel Medical Center at 1 site in Israel.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Pelvic adhesions, particularly between ovaries and pelvic sidewall, frequently complicate endometriosis surgery. Despite various interventions, no widely accepted solution exists. Small studies suggest temporary ovarian suspension may reduce adhesion formation. Read more about this study

Who is it for?
Ages 18 to 50 years, women only
Conditions the study is for
Endometriosis, Abdominal Adhesions
What is being tested?
laparoscopic ovarian suspension
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
76 participants
Where
1 siteIsrael
Study dates
16 Mar 2025to Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with moderate to severe endometriosis with suspected adhesions, lesions in the ovary, ovarian fossa, utero-sacral ligaments, pouch of douglas, or involvement of the intestine as seen in preoperative assessment who are willing to participate in the study including postoperative follow-up assessments.

Who cannot join

  • Patients who are not intended to have an endometriosis operation. Patients with minimal to mild endometriosis and no suspected adhesions or ovarian, ovarian fossa, utero-sacral ligament, pouch of douglas involvement on preoperative assessment.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Yuval Kaufman, MD contact

+97248250336

mdykaufman@gmail.com

Israel1 site, 1 recruiting
  • Carmel Medical Center

    Haifa, 34362

    Yuval Kaufman, MD, +97248250336, mdykaufman@gmail.com

    Recruiting

Other trials in Israel

About this study

Official title: The Effect of Temporary Ovarian Suspension to the Anterior Abdominal Wall During Laparoscopic Endometriosis Surgery for Adhesion Prevention -A Comparative and Prospective Study

Pelvic adhesions, particularly between ovaries and pelvic sidewall, frequently complicate endometriosis surgery. Despite various interventions, no widely accepted solution exists. Small studies suggest temporary ovarian suspension may reduce adhesion formation. This technique, which temporarily elevates ovaries postoperatively, shows promise but requires further investigation to confirm its efficacy and long-term outcomes.

This prospective, single-blinded, randomized controlled study compares adhesion formation in endometriosis patients at risk for ovarian adhesions. Participants are randomized to undergo laparoscopic surgery with temporary ovarian suspension or standard care without ovarian suspension. Pain and suture removal eagerness are assessed via daily questionnaires. Blinded ultrasound experts evaluate adhesions at 6 and 13 weeks postoperatively. No anti-adhesive barriers are used to minimize confounding factors

Read the detailed description

Endometriosis is a chronic condition characterized by growth of endometrial tissue in sites other than the uterine cavity, most commonly in the pelvic cavity, including the ovaries, the uterosacral ligaments, and the pouch of Douglas. Laparoscopic excision of endometriosis lesions has become the gold standard treatment. At follow-up, relief of pain and quality of life after endometriosis surgical treatment ranges between 50% and 95%. However, pelvic surgery for endometriosis has been associated with a high rate of postoperative adhesion formation. The incidence of pelvic adhesions at second-look laparoscopy in the initial few weeks after surgery has been reported to be between 50% and 100%. The ovaries are the most common site involved by adhesions because of their anatomic localization (close to the pelvic sidewall and the homolateral tube) and the fragility of the coelomic epithelium that covers the ovarian surface [7,8]. In addition, when the posterior pelvic compartment is involved, obliteration of the pouch of Douglas is often observed as a result of a post-inflammatory process causing ovarian adhesions [9]. Women with higher risk for postoperative ovarian adhesions include those who have preoperative ovarian adhesions or patients undergoing ovarian cystectomy, peritonectomy of the ovarian fossa or extensive pelvic adhesiolysis. Postoperative retained free fluid with blood and postoperative infections may also increase the risk for adhesions. Postoperative adhesions are a source of major concern because of their potential consequences including persistent pelvic pain, dyspareunia (difficult or painful sexual intercourse), infertility, intestinal obstruction, and complications at subsequent surgery.

A wide range of interventions has been tried in the past in order to reduce postoperative pelvic adhesions. This includes intra-peritoneal administration of anti-adhesive solutions such as icodextrin and hyaluronic acid. Various drugs including steroids and heparin have also been tried in the past but none of them have gained wide acceptance (Metwally et al., 2006; Kamel, 2010). Oxidized regenerated cellulose was found to reduce postoperative adhesion in two very small RCTs (Ahmad et al., 2008).

Intra-operative suspension of the ovaries to the anterior abdominal wall is sometimes used to facilitate ovarian retraction and improve exposure of the pelvis during surgery for severe endometriosis (Cutner et al., 2004). Temporary ovarian suspension can be achieved using a straight needle and absorbable suture to suspend the ovary to the abdominal wall with an external knot tie that can be easily removed at any time after surgery. Two small observational studies suggested that temporary ovarian suspension for 4-7 days following surgery for severe endometriosis may reduce the frequency of postoperative pelvic adhesions (Abuzeid et al., 2002; Ouahba et al., 2004).

The Objective of the Study The primary objective of the study is to examine adhesion formation following laparoscopic surgery with temporary ovarian suspension removed a week after surgery.

The secondary objective is the analyze patient symptoms and adherence to the ovarian suspension as well as request to remove the suture before one week post operative.

Rationale for conducting the study If ovarian suspension is indeed beneficial it can be incorporated as part of common practice for laparoscopic endometriosis surgery.

Methods This is a prospective single-blinded randomized controlled interventional study.

Patients scheduled for laparoscopic surgery due to endometriosis with suspected adnexal adhesions, lesions of the ovary, ovarian fossa, uterosacral ligaments, pouch of Douglas, or involvement of the bowel, as seen by imaging, will be included. A comparison will be made between suspended ovaries in the study group vs. non-suspended ovaries in the control group. During surgery, the primary surgeon will inspect the pelvis. If on the side of the relevant ovary there are adhesions and/or ovarian cyst and/or peritoneal lesions around the ovarian fossa and uterosacral ligament, an ovarian suspension will be performed according to randomization. The randomization process will be based on a preformed list produced by the statistician which will be used during surgery. In case of bilateral pelvic involvement, the left ovary will be the first to be acted on according to the randomization result (i.e suspend/not suspend). In case of ovarian cysts, the surgeon will decide upon treatment method of the cyst during surgery. Suspension of the ovary will be performed using Monocryl absorbable suture. In order to reduce confounding variables, there will be no use of anti-adhesive barriers. Removal of the suspension will be performed at the clinic a week after surgery unless the patient requests to remove the suture earlier. Patients will be asked to fill a daily questionnaire describing the amount of pain according to VAS score they are experiencing due to ovarian suspension and how eager they are to remove the suture prematurely on a scale of 1-10.

Preoperative and postoperative ultrasound evaluation will be performed by one of two dedicated ultrasound experts using a Voluson E10 ultrasound. During postoperative evaluation, the experts will be blinded as to whether ovarian suspension was performed or not. Postoperative ultrasound will be performed 6 and 13 weeks following surgery and will include description of the size of the ovary, location and severity of adhesions.

Statistical analysis will be performed according to each suspended vs non-suspended ovary, i.e. the number of ovaries suspended for the study group vs, the number of non-suspended ovaries in the control group patients.

Being tested
laparoscopic ovarian suspension
Keywords
endometriosis, ovarian suspension, laparoscopy, abdominal adhesions
Medical subject headings
Endometriosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • laparoscopic ovarian suspensionProcedure or surgery

    Suspension of the ovary during laparoscopy for endometriosis

Study groups in NCT07087756
Study groupRoleWhat they receive
Suspended OvaryActive comparatorOvary suspended during laparoscopy for endometriosis surgery
Receives: Procedure: laparoscopic ovarian suspension
Non-suspended ovarySham comparatorOvaries not suspended during laparoscopy for endometriosis
Receives: Procedure: laparoscopic ovarian suspension

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adhesion formation following laparoscopic surgery with temporary ovarian suspension as assessed in post-operative ultrasound visits at weeks 6,13 following surgery

    The primary objective of the study is to examine adhesion formation following laparoscopic surgery with temporary ovarian suspension removed a week after surgery. Assessment of adhesions will be performed by ultrasound before surgery and then at 6 week and 13-week post-surgery. Assessment will be performed by an ultrasound specialist who is blinded to the surgical procedure. Adhesions are marked as negative or positive per organ including left and right ovary, left and right tube and other locations (rectosigmoid, uterus, bladder, pouch of Douglas).

    Measured: From enrollment to last follow-up visit at 13 weeks post surgery

Secondary outcomes (2)
  1. Patient pain during the first week following laparoscopy

    The secondary objective is to analyze patient pain symptoms during the first week after surgery. Patients will report pain symptoms daily, as measured by Visual Analog Score for pain on a scale of 0-10.

    Measured: From enrollment to 1 week post-operative follow-up visit

  2. Patient tolerability to ovarian suspension during the first week following surgery

    Patient will report daily on their eagerness to remove the suture temporarily suspending each ovary to the abdominal wall on a scale from 0 to 10 during the first week after surgery.

    Measured: From enrollment to 1 week post-operative follow-up visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2025
  2. Study start16 Mar 2025
  3. Primary completionMar 2027 (estimated)
  4. Study completionJul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
76 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07087756
Sponsor's protocol ID
CMC-0110-24
Status last verified
Jul 2025
First submitted
26 Jun 2025
Last updated
28 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Patients outcomes

Publications

  • Davey AK, Maher PJ. Surgical adhesions: a timely update, a great challenge for the future. J Minim Invasive Gynecol. 2007 Jan-Feb;14(1):15-22. doi: 10.1016/j.jmig.2006.07.013.

    PubMed 17218224
  • Hudelist G, Fritzer N, Staettner S, Tammaa A, Tinelli A, Sparic R, Keckstein J. Uterine sliding sign: a simple sonographic predictor for presence of deep infiltrating endometriosis of the rectum. Ultrasound Obstet Gynecol. 2013 Jun;41(6):692-5. doi: 10.1002/uog.12431.

    PubMed 23400893
  • diZerega GS, Campeau JD. Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update. 2001 Nov-Dec;7(6):547-55. doi: 10.1093/humupd/7.6.547.

    PubMed 11727863
  • Kavic SM, Kavic SM. Adhesions and adhesiolysis: the role of laparoscopy. JSLS. 2002 Apr-Jun;6(2):99-109.

    PubMed 12113430
  • diZerega GS. Contemporary adhesion prevention. Fertil Steril. 1994 Feb;61(2):219-35. doi: 10.1016/s0015-0282(16)56507-8.

    PubMed 8299773
  • Mabrouk M, Montanari G, Guerrini M, Villa G, Solfrini S, Vicenzi C, Mignemi G, Zannoni L, Frasca C, Di Donato N, Facchini C, Del Forno S, Geraci E, Ferrini G, Raimondo D, Alvisi S, Seracchioli R. Does laparoscopic management of deep infiltrating endometriosis improve quality of life? A prospective study. Health Qual Life Outcomes. 2011 Nov 6;9:98. doi: 10.1186/1477-7525-9-98.

    PubMed 22054310
  • Ouahba J, Madelenat P, Poncelet C. Transient abdominal ovariopexy for adhesion prevention in patients who underwent surgery for severe pelvic endometriosis. Fertil Steril. 2004 Nov;82(5):1407-11. doi: 10.1016/j.fertnstert.2004.03.060.

    PubMed 15533368
  • Garry R, Clayton R, Hawe J. The effect of endometriosis and its radical laparoscopic excision on quality of life indicators. BJOG. 2000 Jan;107(1):44-54. doi: 10.1111/j.1471-0528.2000.tb11578.x.

    PubMed 10645861
  • Garry R. Laparoscopic excision of endometriosis: the treatment of choice? Br J Obstet Gynaecol. 1997 May;104(5):513-5. doi: 10.1111/j.1471-0528.1997.tb11523.x. No abstract available.

    PubMed 9166188
  • Farquhar C. Endometriosis. BMJ. 2007 Feb 3;334(7587):249-53. doi: 10.1136/bmj.39073.736829.BE. No abstract available.

    PubMed 17272567

Questions about this trial

What is this clinical trial studying?

A study testing laparoscopic ovarian suspension in people with Endometriosis and Abdominal Adhesions, run by Carmel Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yuval Kaufman, MD (+97248250336, mdykaufman@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adhesion formation following laparoscopic surgery with temporary ovarian suspension as assessed in post-operative ultrasound visits at weeks 6,13 following surgery (time frame: From enrollment to last follow-up visit at 13 weeks post surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07087756, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in